Anti-CD20 (Rituximab biosimilar - mIgG2a isotype)
Product | Unit size | Cat. code | Docs. | Qty. | Price | |
---|---|---|---|---|---|---|
Anti-hCD20-mIgG2a Human CD20 (Rituximab) antibody - Murine IgG2a |
Show product |
100 µg 3 x 100 µg |
hcd20-mab10
|
|
Murine IgG2a monoclonal antibody (mAb) against human CD20
Anti-hCD20-mIgG2a features the constant region of the mouse IgG2a isotype and the variable region of rituximab.
Rituximab is a mouse/human chimeric monoclonal antibody that targets the CD20 antigen found on the surface of malignant and normal B lymphocytes.
Binding of rituximab to CD20 results in cell destruction through different mechanisms including direct signaling of apoptosis, complement activation and cell-mediated cytotoxicity.
Rituximab has been approved by the FDA to treat various lymphoid malignancies, including B-cell non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukaemia.
Anti-hCD20-mIgG2a was generated by recombinant DNA technology. It has been produced in Chinese hamster ovary (CHO) cells and purified by affinity chromatography with protein A.
More isotypes of this antibody are available and can be used for comparison of biological activities such as ADCC (see below or in the 'upon request' section). InvivoGen also provides type I and type II anti-hCD20 mAbs featuring the variable regions of Ofatumumab or Obinutuzumab, with either native or engineered Fc regions.
Back to the topSpecifications
Target: Human CD20
Clonality: Monoclonal antibody
Clone: Rituximab (Anti-hCD20-hIgG1, kappa)
Isotype: Mouse IgG2a, kappa
Control: Mouse IgG2a
Source: CHO cells
Formulation: 0.2 µm filtered solution in 68 mM sodium phosphate buffer (pH 7.4) with 91 mM glycine, 5% w/v saccharose, and stabilizing agents
Purity: Purified by affinity chromatography with protein A
Tested application: Flow cytometry and ADCC
Quality control:
- Binding of Anti-hCD20-mIgG2a to human CD20 has been tested using flow cytometry.
- The complete sequence of this antibody has been verified.
- The absence of bacterial contamination (e.g. lipoproteins and endotoxins) has been confirmed using HEK-Blue™ TLR2 and HEK-Blue™ TLR4 cells.
Contents
Anti-hCD20-mIgG2a purified monoclonal antibody is provided azide-free and lyophilized. It is available in two quantities:
- hcd20-mab10: 100 µg
- hcd20-mab10-03: 3 x 100 µg
Product is shipped at room temperature.
Upon receipt, store lyophilized antibody at -20°C.
Back to the top